Assessment of Sleep Status and Possibilities for Correcting Identified Disorders in School-age Children

Sleep disorders in children are an important medical and social problem associated with a decrease in the quality of life and overall health due to the influence of the child’s cognitive, psychological and physical well-being. The objective: to summarize modern scientific data and personal observations regarding the problem of sleep and the possibilities of correcting sleep disorders in children. Materials and methods. An analysis of the sleep characteristics of 62 schoolchildren aged 12 to 18 years in the non-acute period of acute respiratory pathology and with manifestations of vegetative dysfunctions of varying degrees was carried out. The study was carried out in 3 stages: 1 – questioning patients to identify complaints of sleep disorders; 2 – prescribing and taking the drug (Coffea 30CH 20 mg, Coffea 200CH 20 mg, Arnica 30CH 20 mg, Ignatia 1000CH 20 mg, Cimicifuga 200CH 20 mg) according to the scheme of 5 granules before bedtime for three months; 3 – conducting a retest after treatment. The Pittsburgh Sleep Quality Questionnaire (PSQI) was used to determine the quality of sleep. Results. Among the 62 children examined, 35 (56.5%) schoolchildren actively complained of sleep disturbances with a total score on the PSQI questionnaire of 8.25 ± 1.78 points and changes in the PSQI components: subjective sleep quality, sleep latency, usual sleep efficiency, sleep duration, sleep disturbances and daytime functioning disturbances, which corresponded to the average degree of severity (1–2 points). After treatment with the drug statistically significant changes in the total score of the PSQI sleep quality assessment were found – 6.11 ± 0.96 points after treatment versus 8.25 ± 1.78 points before treatment (p < 0.001). According to the PSQI structure, clinical improvement was observed within each component: subjective sleep quality (p < 0.05), sleep delay (sleep latency) (p < 0.001), sleep duration (p < 0.001), sleep efficiency (p = 0.283), sleep disturbance (p = 0.677), daytime dysfunction (p < 0.001). There were no adverse reactions during the use. Conclusions. The complex drug (Coffea 30CH 20 mg, Coffea 200CH 20 mg, Arnica 30CH 20 mg, Ignatia 1000CH 20 mg, Cimicifuga 200CH 20 mg) has a positive effect on the treatment of sleep disorders in children with autonomic dysfunctions. The absence of side effects, good tolerability, the possibility of long-term use and affordable price allow us to recommend the drug for widespread use.